POAI Margin dodolan resik Predictive Oncology Inc.

Logo perusahaan publik Predictive Oncology Inc. (POAI)

The global expansion of Predictive Oncology (POAI) is constrained by export controls and supply chain disruptions from Asia. Adjusted net profit margins reflect the impact of unique AI algorithms on service costs for pharma behemoths, with the current metric standing at -11604.30. However, high R&D costs are leading to a liquidity shortage and a rapid burn rate of the company's existing cash reserves.

Rentabilitas dodolan resik Predictive Oncology Inc (POAI): kanggo periode 04.07.2022 - 12.12.2025

Ringkesan rincian data analitis Predictive Oncology Inc. (POAI)

- nilai pasar lan prakiraan target analis:
Analisis umum perusahaan:Predictive Oncology
Produk asil prodhuksi predictive-oncology.com

For Predictive Oncology (POAI), the net margin percentage reflects the portion of profit derived from every dollar of revenue. This indicator reveals hidden efficiency degradation, where a decline in profitability despite stable sales signals a systemic crisis. The metric is sensitive to the inflation of operating expenses relative to income. Given the dependence on the R&D budgets of pharma behemoths, cost control becomes critical. The technological superiority of the AI platform allows the business to remain within a safe range.

Karo sapa Predictive Oncology saingan

Intuitive Surgical, Inc. (ISRG) - Margin resik|Margin resik Danaher Corporation (DHR)|Margin resik Becton Dickinson & Co|Rentabilitas dodolan resik STE (STERIS plc)|Rentabilitas dodolan miturut bathi resik WST (West Pharmaceutical Services Inc)|Rentabilitas resik perusahaan BAX|Masimo Corporation - Rentabilitas dodolan miturut bathi resik|Rentabilitas resik perusahaan STVN (Stevanato Group SpA)|TFX: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan Merit Medical Corp MMSI|NVST: Margin dodolan resik|ICUI - Margin dodolan perusahaan|XRAY (Sirona Dental Systems) - Margin dodolan resik|Margin resik LeMaitre Vascular Inc LMAT|Margin resik AtriCure Corp (ATRC)|Margin dodolan resik STAAR Surgical Corp (STAA)|Margin resik niagenbioscience.com NAGE|ZimVie Inc. - Margin resik|ANGO - Margin resik|Margin dodolan perusahaan Cerus Corp CERS|TKNO (Alpha Teknova Inc) - Rentabilitas dodolan miturut bathi resik|Monogram Technologies Inc - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik STSS|InfuSystem Holdings, Inc. (INFU) - Margin dodolan perusahaan|Margin dodolan resik UTMD|KORU Medical - Rentabilitas dodolan resik|Nyxoah S.A - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik MBOT|PDEX - Margin resik|ZTEK (Zentek) - Rentabilitas dodolan resik|ELUT (Elutia Inc) - Rentabilitas dodolan miturut bathi resik|MLSS - Margin dodolan perusahaan|Margin resik NEXGEL, Inc.|RVP (Retractable Technologies) - Rentabilitas resik perusahaan|Margin dodolan resik HBIO|FEMY: Margin bathi resik|Margin resik MeihuaMed MHUA|CJMB - Rentabilitas dodolan miturut bathi resik|ATRI: Rentabilitas dodolan miturut bathi resik|NeuroMetrix, Inc. (NURO) - Rentabilitas dodolan miturut bathi resik